| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |